Patents by Inventor Bhagwati P. Kabra

Bhagwati P. Kabra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL SUSPENSION
    Publication number: 20100144719
    Abstract: The present invention is directed to the provision of a pharmaceutical suspension. The suspension includes high molecular weight polyethylene glycol as a suspending agent. The suspension also typically includes an antimicrobial agent (e.g., polymeric quaternary ammonium compound), an antimicrobial system (e.g., borate/polyol complex system) or both. The suspension has been found particularly useful as an ophthalmic suspension, but can be used in other instances as well.
    Type: Application
    Filed: December 3, 2009
    Publication date: June 10, 2010
    Inventor: Bhagwati P. Kabra
  • Pharmaceutical compositions for otic use
    Patent number: 7727549
    Abstract: Otic compositions are disclosed. The compositions contain an otic drug and a carrier comprising a low molecular weight compound. The compositions do not drain out of the ear after administration.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: June 1, 2010
    Assignee: Alcon, Inc.
    Inventor: Bhagwati P. Kabra
  • Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
    Patent number: 7678827
    Abstract: Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: March 16, 2010
    Assignee: Alcon, Inc.
    Inventors: Bhagwati P. Kabra, Janet D. Howie
  • PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY
    Publication number: 20090234013
    Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.
    Type: Application
    Filed: March 13, 2009
    Publication date: September 17, 2009
    Inventor: Bhagwati P. Kabra
  • LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION
    Publication number: 20090233890
    Abstract: Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection.
    Type: Application
    Filed: March 10, 2009
    Publication date: September 17, 2009
    Applicant: Alcon Research, Ltd.
    Inventors: Bhagwati P. Kabra, Ruma Sarkar
  • PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY
    Publication number: 20090234004
    Abstract: The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.
    Type: Application
    Filed: March 13, 2009
    Publication date: September 17, 2009
    Inventors: Bhagwati P. Kabra, Nuria Carreras, Monica Cuchi, Francisco Javier Galan, Mridvika, Elena Gonzalez Puig, Nuria Jimenez, Carmen Martinez
  • AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES
    Publication number: 20090232763
    Abstract: The present invention is directed to the provision of multi-dose, ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP). The compositions include at two different polyols in conjunction with borate, a preservative or both.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 17, 2009
    Inventors: Bhagwati P. Kabra, Rajni Jani
  • Non-Polymeric Lipophilic Pharmaceutical Implant Compositions For Intraocular Use
    Publication number: 20080241224
    Abstract: Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.
    Type: Application
    Filed: June 3, 2008
    Publication date: October 2, 2008
    Applicant: Alcon, Inc.
    Inventors: Bhagwati P. Kabra, Janet D. Howie
  • PACKAGING MATERIALS FOR FORMULATIONS CONTAINING 2-PYRROLIDONE DERIVATIVES
    Publication number: 20080093247
    Abstract: Packaging materials substantially lacking adsorptive and absorptive properties for 2-pyrrolidone derivatives are provided. The packaged products described herein provide for retention of the 2-pyrrolidone derivative within the formulation thereby maintaining the integrity of such formulations. Packaged products are useful for ophthalmic, otic, and nasal applications. Ophthalmic application includes therapeutic uses and contact lens care uses.
    Type: Application
    Filed: October 24, 2007
    Publication date: April 24, 2008
    Applicant: Alcon Manufacturing Ltd.
    Inventors: Wesley Wehsin Han, Masood A. Chowhan, Jang-Shing Chiou, L. Wayne Schneider, Bhagwati P. Kabra
  • Bioerodible film for ophthalmic drug delivery
    Publication number: 20040126408
    Abstract: Drug delivery film compositions containing a combination of a water-soluble, film-forming polymers and a fatty acid glyceride or ester are suitable for delivering ophthalmic drugs.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 1, 2004
    Applicant: Alcon, Inc.
    Inventors: Bhagwati P. Kabra, Janet D. Howie, Youqin Tian, David Allen Marsh, Gustav Graff
  • Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
    Publication number: 20040013704
    Abstract: Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.
    Type: Application
    Filed: June 30, 2003
    Publication date: January 22, 2004
    Applicant: Alcon, Inc.
    Inventors: Bhagwati P. Kabra, Janet D. Howie
  • Pharmaceutical compositions for otic use
    Publication number: 20040014819
    Abstract: Otic compositions are disclosed. The compositions contain an otic drug and a carrier comprising a low molecular weight compound. The compositions do not drain out of the ear after administration.
    Type: Application
    Filed: June 30, 2003
    Publication date: January 22, 2004
    Applicant: Alcon, Inc.
    Inventor: Bhagwati P. Kabra
  • Topical composition comprising ciprofloxacin and hydrocortisone
    Publication number: 20020037884
    Abstract: This invention is directed toward a topical composition comprising ciprofloxacin and hydrocortisone, where the composition contains a specific grade of polyvinyl alcohol as a viscosity augmenter. The specified grade of polyvinyl alcohol is 85-90% hydrolyzed polyvinyl alcohol.
    Type: Application
    Filed: July 16, 2001
    Publication date: March 28, 2002
    Applicant: Alcon Universal Ltd.
    Inventors: Onkar N. Singh, Haresh G. Bhagat, Bhagwati P. Kabra
  • Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
    Patent number: 6331540
    Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug, xanthan gum and a water-soluble calcium salt in an amount sufficient to make the fluoroquinolone antibiotic drug and xanthan gum compatible are disclosed.
    Type: Grant
    Filed: October 10, 2000
    Date of Patent: December 18, 2001
    Assignee: Alcon Universal Ltd.
    Inventor: Bhagwati P. Kabra
  • Gelling ophthalmic compositions containing xanthan gum
    Patent number: 6261547
    Abstract: Ophthalmic drug delivery vehicles which are administrable as a liquid and which gel upon contact with the eye are disclosed. The vehicles contain xanthan gum and an ophthalmically acceptable anesthetic agent.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: July 17, 2001
    Assignee: Alcon Manufacturing, Ltd.
    Inventors: Rajan Bawa, Rex E. Hall, Bhagwati P. Kabra, James E. Teague, Gerald D. Cagle, Kerry L. Markwardt, Mandar V. Shah
  • Gelling ophthalmic compositions containing xanthan gum
    Patent number: 6174524
    Abstract: Ophthalmic drug delivery vehicles which are administrable as a liquid and which gel upon contact with the eyes are disclosed. The vehicles contain xanthan gum.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: January 16, 2001
    Assignee: Alcon Laboratories, Inc.
    Inventors: Rajan Bawa, Rex E. Hall, Bhagwati P. Kabra, James E. Teague
  • Thermally-gelling emulsions
    Patent number: 5827835
    Abstract: Thermally gelling emulsion compositions which reversibly increase in either loss modulus or storage modulus, or both, upon contact with the eye, skin, mucous membrane or body cavity are disclosed. The emulsion compositions contain one or more nonionic substituted cellulose ethers and do not require a charged surfactant or a pH-sensitive polymer for such increase in loss modulus or storage modulus, or both, upon administration. In one embodiment, the compositions gel upon instillation in the eye.
    Type: Grant
    Filed: December 3, 1996
    Date of Patent: October 27, 1998
    Assignee: Alcon Laboratories, Inc.
    Inventor: Bhagwati P. Kabra
  • Thermally-gelling drug delivery vehicles containing cellulose ethers
    Patent number: 5618800
    Abstract: Drug delivery vehicles which reversibly increase in either loss modulus or storage modulus, or both, upon contact with the eye, skin, mucous membrane or body cavity are disclosed. The vehicles contain one or more nonionic substituted cellulose ethers and do not require a charged surfactant or a pH-sensitive polymer for such increase in loss modulus or storage modulus, or both, upon administration. In one embodiment, the vehicles gel upon instillation in the eye.
    Type: Grant
    Filed: August 23, 1995
    Date of Patent: April 8, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Bhagwati P. Kabra, John C. Lang